These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

617 related items for PubMed ID: 29440899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Targeted Delivery of Doxorubicin Liposomes for Her-2+ Breast Cancer Treatment.
    Chowdhury N, Chaudhry S, Hall N, Olverson G, Zhang QJ, Mandal T, Dash S, Kundu A.
    AAPS PharmSciTech; 2020 Jul 21; 21(6):202. PubMed ID: 32696338
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. RNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivo.
    Baek SE, Lee KH, Park YS, Oh DK, Oh S, Kim KS, Kim DE.
    J Control Release; 2014 Dec 28; 196():234-42. PubMed ID: 25450401
    [Abstract] [Full Text] [Related]

  • 6. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A, Salmaso S, Eldar-Boock A, Ben-Shushan D, Ferber S, Tiram G, Shmeeda H, Landa-Rouben N, Leor J, Caliceti P, Gabizon A, Satchi-Fainaro R.
    J Control Release; 2015 Jun 28; 208():106-20. PubMed ID: 25869964
    [Abstract] [Full Text] [Related]

  • 7. Targeted co-delivery of FOXM1 aptamer and DOX by nucleolin aptamer-functionalized pH-responsive biocompatible nanodelivery system to enhance therapeutic efficacy against breast cancer: in vitro and in vivo.
    Masoudi M, Taghdisi SM, Hashemitabar G, Abnous K.
    Drug Deliv Transl Res; 2024 Jun 28; 14(6):1535-1550. PubMed ID: 38161196
    [Abstract] [Full Text] [Related]

  • 8. Anti-epithelial cell adhesion molecule RNA aptamer-conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model.
    Mashreghi M, Zamani P, Karimi M, Mehrabian A, Arabsalmani M, Zarqi J, Moosavian SA, Jaafari MR.
    Biotechnol Prog; 2021 May 28; 37(3):e3116. PubMed ID: 33369269
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Increasing the antitumor efficacy of doxorubicin liposomes with coupling an anti-EGFR affibody in EGFR-expressing tumor models.
    Jia D, Yang Y, Yuan F, Fan Q, Wang F, Huang Y, Song H, Hu P, Wang R, Li G, Liu R, Li J.
    Int J Pharm; 2020 Aug 30; 586():119541. PubMed ID: 32544521
    [Abstract] [Full Text] [Related]

  • 12. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
    Saravanakumar K, Hu X, Shanmugam S, Chelliah R, Sekar P, Oh DH, Vijayakumar S, Kathiresan K, Wang MH.
    Arch Biochem Biophys; 2019 Aug 15; 671():143-151. PubMed ID: 31283911
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A, Tzemach D, Gorin J, Mak L, Amitay Y, Shmeeda H, Zalipsky S.
    Cancer Chemother Pharmacol; 2010 May 15; 66(1):43-52. PubMed ID: 19779718
    [Abstract] [Full Text] [Related]

  • 15. Tat peptide and hexadecylphosphocholine introduction into pegylated liposomal doxorubicin: An in vitro and in vivo study on drug cellular delivery, release, biodistribution and antitumor activity.
    Teymouri M, Badiee A, Golmohammadzadeh S, Sadri K, Akhtari J, Mellat M, Nikpoor AR, Jaafari MR.
    Int J Pharm; 2016 Sep 10; 511(1):236-244. PubMed ID: 27363937
    [Abstract] [Full Text] [Related]

  • 16. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
    Paliwal SR, Paliwal R, Mishra N, Mehta A, Vyas SP.
    Curr Cancer Drug Targets; 2010 May 10; 10(3):343-53. PubMed ID: 20370682
    [Abstract] [Full Text] [Related]

  • 17. Heparan sulfate targeting strategy for enhancing liposomal drug accumulation and facilitating deep distribution in tumors.
    Kuo PH, Teng YH, Cin AL, Han W, Huang PW, Wang LH, Chou YT, Yang JL, Tseng YL, Kao M, Chang MD.
    Drug Deliv; 2020 Dec 10; 27(1):542-555. PubMed ID: 32241176
    [Abstract] [Full Text] [Related]

  • 18. Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes.
    Song X, Ren Y, Zhang J, Wang G, Han X, Zheng W, Zhen L.
    Oncol Rep; 2015 Oct 10; 34(4):1953-60. PubMed ID: 26238192
    [Abstract] [Full Text] [Related]

  • 19. Biotin-Conjugated Multilayer Poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene Glycol Nanoparticles for Targeted Delivery of Doxorubicin.
    Dai Y, Xing H, Song F, Yang Y, Qiu Z, Lu X, Liu Q, Ren S, Chen X, Li N.
    J Pharm Sci; 2016 Sep 10; 105(9):2949-2958. PubMed ID: 27209461
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.